Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2a Study of 0.05% Difluprednate Ophthalmic Emulsion in the Treatment of Postoperative Inflammation

NCT00406497 is registered in ClinicalTrials.gov with Sirion Therapeutics, Inc. as lead sponsor.

NCT NCT00406497
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00406497 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2a Study of 0.05% Difluprednate Ophthalmic Emulsion in the Treatment of Postoperative Inflammation
Lead sponsor
Sirion Therapeutics, Inc.
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2003
Completion date
July 31, 2003
Enrollment
24
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

inflammation